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Campylobacter jejuni outer membrane vesicles (OMVs) contain numerous virulence-
associated proteins including the cytolethal distending toxin and three serine proteases.
As C. jejuni lacks the classical virulence-associated secretion systems of other enteric
pathogens that deliver effectors directly into target cells, OMVs may have a particularly
important role in virulence. C. jejuni OMV production is stimulated by the presence
of physiological concentrations of the bile salt sodium taurocholate (ST) through an
unknown mechanism. The maintenance of lipid asymmetry (MLA) pathway has been
implicated in a novel mechanism for OMV biogenesis, open to regulation by host signals.
In this study we investigated the role of the MLA pathway in C. jejuni OMV biogenesis
with ST as a potential regulator. OMV production was quantified by analyzing protein
and lipid concentrations of OMV preparations and OMV particle counts produced by
nanoparticle tracking analysis. Mutation of mlaA which encodes the outer membrane
component of the MLA pathway significantly increased OMV production compared to the
wild-type strain. Detergent sensitivity and membrane permeability assays confirmed the
increased OMV production was not due to changes in membrane stability. The presence
of 0.2% (w/v) ST increased wild-type OMV production and reduced OMV size, but did not
further stimulate mlaA mutant OMV production or significantly alter mlaA mutant OMV
size. qRT-PCR analysis demonstrated that the presence of ST decreased expression
of both mlaA and mlaC in C. jejuni wild-type strains 11168 and 488. Collectively the
data in this study suggests C. jejuni can regulate OMV production in response to
host gut signals through changes in expression of the MLA pathway. As the gut bile
composition is dependent on both diet and the microbiota, this study highlights the
potential importance of diet and lifestyle factors on the varying disease presentations
associated with gut pathogen infection.
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INTRODUCTION
Campylobacter jejuni is a microaerophilic Gram-
negative bacterium that is the leading cause of foodborne
bacterial gastroenteritis worldwide (Silva et al., 2011; Kaakoush
et al., 2015). Whilst C. jejuni has a number of potential virulence
factors, including a cytolethal distending toxin (Lindmark et al.,
2009; Elmi et al., 2012), and multiple proteases (Karlyshev
et al., 2014; Elmi et al., 2016, 2018), Campylobacter jejuni lacks
the classical virulence associated secretion systems of other
enteric pathogens that deliver effectors directly to target cells
(Parkhill et al., 2000). A Type VI secretion system (T6SS) has
been identified in a proportion of strains, however, the function
and variability of T6SSs among C. jejuni strains is still poorly
understood (Bleumink-Pluym et al., 2013; Ugarte-Ruiz et al.,
2015). An alternative machinery to deliver potential virulence
determinants are outer membrane vesicles (OMVs), which can
act as a general secretion pathway among Gram-negative bacteria
and maybe are of particular importance for C. jejuni virulence
and survival.
OMVs are small spherical membrane-bound structures
ranging in size from 10 to 500 nm in diameter formed from
the outer membrane of Gram-negative bacteria and released
into the extracellular environment (Kuehn and Kesty, 2005;
Schwechheimer and Kuehn, 2015). OMVs provide a mechanism
to deliver cargo in concentrated, selectively packaged parcels,
protected from the extracellular environment with the potential
for site specific targeting to receptors on cells (Kuehn and Kesty,
2005; Bomberger et al., 2009; Bonnington and Kuehn, 2014; Bitto
et al., 2017). OMV production appears evolutionarily conserved
in Gram-negative bacteria despite being metabolically energy
consuming, suggesting OMVs have vital roles (Kulp and Kuehn,
2010; Roier et al., 2016). OMV production has been observed
under a range of conditions in both pathogenic and non-
pathogenic Gram-negative bacteria (Mashburn-Warren et al.,
2008; Elmi et al., 2012; Altindis et al., 2014; Zakharzhevskaya
et al., 2017); both on solid and in liquid media (Schooling and
Beveridge, 2006; Schwechheimer and Kuehn, 2015), and in the
presence or absence of stress (Schwechheimer and Kuehn, 2015).
Conditions or gene mutations resulting in the absence of OMVs
have not been identified. OMVs have been suggested to have
a variety of functions important in survival and virulence via
processes such as competition for growth (Manning and Kuehn,
2011; Kulkarni et al., 2015), immunomodulation (Koeppen et al.,
2016; Tsatsaronis et al., 2018), biofilm formation (Schooling
and Beveridge, 2006), bacterial communication (Mashburn and
Whiteley, 2005; Mashburn-Warren et al., 2008), and the delivery
of biomolecules such as toxins (Bielaszewska et al., 2017; Elmi
et al., 2018).
Until recently there has been no general regulatory model
for OMV biogenesis that could be widely applicable to Gram-
negative bacteria. The three main OMV biogenesis models
proposed previously have been based on either changes in cell
wall to outer membrane (OM) linkages, stress or a species-
specific mechanism. One previously proposed model suggests
that the build-up of cellular components (such as misfolded
proteins due to heat shock, or peptidoglycan fragments due
to cell wall remodeling defects) at the OM result in bulging
and subsequent blebbing (Zhou et al., 1998; Mcbroom and
Kuehn, 2007). OMVs have since been demonstrated to contain
biologically active cargo and not just cell waste (Mashburn and
Whiteley, 2005; Bielaszewska et al., 2017; Elmi et al., 2018). A
second mechanism proposed that the reduction in cell wall to
OM interactions can cause areas prone to blebbing. This has
been demonstrated by OMVs being released at cell division sites
with high frequency (Kulp and Kuehn, 2010), however, OMV
release is not restricted to cell division sites (Elhenawy et al.,
2016). Deatherage et al. (2009) studied the effect of removing cell
wall to OM linkages on OMV production and found removal
of OmpA linkages did not compromise the cell membrane.
However, removal of other linkages (lpp, tolA, tolB, and pal) did
cause membrane defects. Additional studies have found that the
down-regulation of ompA is dependent on the membrane stress
sigma factor, σE (Song et al., 2008). A further mechanism has
been identified in the OM of Pseudomonas aeruginosa, which
has increased fluidity compared to the OM of other Gram-
negative bacteria. Pseudomonas aeruginosa produces a quorum
sensing molecule PQS (pseudomonas quinolone signal) which
induces membrane curvature through interactions with lipid A
to stabilize and reduce fluidity of the OM. Without PQS, P.
aeruginosa struggles to reach the membrane curvature necessary
to form OMVs. However, this proposed mechanism appears
specific to P. aeruginosa cells (Mashburn and Whiteley, 2005;
Mashburn-Warren et al., 2008).
More recently, Roier et al. (2016) have proposed a new general
regulatory model based on the maintenance of lipid asymmetry
pathway (MLA) that could be widely applicable to Gram-negative
bacteria. The MLA pathway has been shown to play a role in
the retrograde trafficking of phospholipids (PLs) from the outer
leaflet of the OM to the inner membrane. The core components
of this pathway are highly conserved in Gram-negative bacteria
(Malinverni and Silhavy, 2009). The pathway consists of an inner
membrane ABC (ATP binding cassette) transporter consisting
of MlaBDEF (MlaB is absent in α and ε proteobacteria), a
periplasmic chaperone MlaC, and the OM lipoprotein MlaA.
The components of the MLA pathway are homologous to
YrbBCDEF and VacJ in Haemophilus influenzae. Roier et al.
proposed that down-regulation or mutation of the MLA pathway
or components of this pathway will lead to an accumulation
of PLs in the outer leaflet of the OM. This accumulation leads
to an asymmetric expansion which eventually results in the
formation of an OMV. Roier et al. demonstrated increased
OMV production in mla mutants, as well as reduced mla
gene expression in H. influenzae under iron-limiting conditions.
The same study suggested that iron limitation signaled entry
to the host nasopharynx, and the subsequent increase in
OMV production was a potential mechanism to defend against
antibody and complement-mediated attack.
A range of virulence factors have been identified within
C. jejuni OMVs, including the cytolethal distending toxin and
putative virulence-associated proteases that contribute to C.
jejuni invasion into intestinal epithelial cells (Lindmark et al.,
2009; Elmi et al., 2016, 2018). C. jejuni OMVs isolated at
37◦C (human body temperature) have also been shown to
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differ in protein abundance compared to 42◦C (avian body
temperature), suggesting C. jejuni can alter cargo in response
to host signals (Taheri et al., 2019). An important feature of
a pathogen is the ability to sense the environment and to
appropriately alter and co-ordinate the regulation of virulence
factors. We have previously reported the potential significance
of the bile salt sodium taurocholate (ST) in the regulation of
OMV-mediated virulence in C. jejuni (Elmi et al., 2018) and
have demonstrated increased OMV production in the presence
of physiologically relevant concentrations of ST. In addition,
the OMVs isolated from cultures supplemented with ST (ST-
OMVs) exhibited increased proteolytic activity, cytotoxicity, and
immunogenicity to intestinal epithelial cells. ST has also been
shown to up-regulate virulence gene expression inVibrio cholerae
by causing alterations in disulphide bond formation in TcpP
(transmembrane transcription factor) (Yang et al., 2013).
This study further investigates the link between the MLA
pathway and OMV production in Gram-negative bacteria.
Increased OMV production without compromising membrane
stability was observed in a C. jejuni 11168 mlaA mutant.
This study also builds on previous work linking the bile salt
ST to increased OMV production, by identifying a potential
mechanism for the ST-OMV phenotype. OMV production was
observed to increase in the C. jejuni wild-type strain, but not in
the mlaA mutant in the presence of ST. Growth of C. jejuni in
the presence of ST also resulted in reduced expression of mla
genes. The data in this study supports the MLA model of OMV
production and the link between bile salts and potential virulence
regulation in C. jejuni.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The C. jejuni wild-type strains used in this study were NCTC
11168 (the widely studied human clinical isolate) and 488 (a
recent Brazilian human isolate obtained from Daiani Teixeira
Da Silva). Cultures were grown in a microaerobic chamber
(Don Whitley Scientific, United Kingdom) containing 85%
(v/v) N2, 10% (v/v) CO2, and 5% (v/v) O2 at 37
◦C either on
blood agar (BA) plates containing Columbia agar base (Oxoid,
United Kingdom), 7% (v/v) horse blood (TCS Microbiology,
United Kingdom), and Campylobacter Selective Supplement
(Oxoid), or in Brucella broth (Oxoid) shaking at 75 rpm unless
otherwise stated. C. jejuni strains were grown on BA plates for
24 h prior to experiments unless otherwise stated. Escherichia coli
XL2-Blue MRF’ competent cells (Stratagene, United Kingdom)
were used for cloning and were grown at 37◦C in aerobic
conditions either in Lysogeny broth (LB) (Oxoid) shaking at 200
rpm or on LB agar plates (Oxoid). When required, ampicillin
(100µg/ml), kanamycin (50µg/ml), apramycin (60µg/ml), or
chloramphenicol (50µg/ml for E. coli or 10µg/ml for C. jejuni)
were added to cultures.
Construction of C. jejuni Mutants
The C. jejuni 11168 mlaA gene was inactivated by deletion of
the reading frame by homologous cross-over and replacement
with a kanamycin resistance cassette. The mutation vector
was created using the Gibson isothermal assembly method as
previously described (Taylor et al., 2017). The C. jejuni 11168
wild-type strain was transformed by electroporation and mutant
clones selected for kanamycin resistance. Correct insertion and
orientation of the kanamycin cassette into the genome was
confirmed by PCR.
The C. jejuni 488 mlaA mutant was constructed by
natural transformation using genomic DNA from the C. jejuni
11168 mlaA mutant spotted onto the C. jejuni 488 wild-type
strain. Transformations were performed on Mueller-Hinton
agar (Oxoid) plates for 5 h under microaerobic conditions at
37◦C. Transformants were screened on BA plates supplemented
with kanamycin, then putative mutants verified by PCR
and sequencing.
Complementation of C. jejuni mlaA
Mutants
Complementation of the C. jejuni 11168 mlaA mutant
was performed using the pRRA system to generate a
complementation vector as previously described (Taylor
et al., 2017). The 11168 mlaA mutant was transformed with the
complementation vector by electroporation and clones selected
for apramycin resistance. Correct insertion of the expression
cassette into the genome was confirmed by PCR. In the 11168
mlaA complement strain, the inserted mlaA gene is under the
control of the native promoter.
The C. jejuni 488 mlaA mutant was complemented using
the pCJC1 complementation vector as previously described
TABLE 1 | Primers used in this study.
Primer name Primer sequence 5′-3′ Source
GSmlaA(F) TAGGAGTTTTTGCTGAG This study
GSmlaA(R) GCTAAGTTCATTGCGTC This study
ISAmlaA(F1) GAGCTCGGTACCCGGGGATCCT
CTAGAGTCTGGCACTACAATAAATAAGG
This study
ISAmlaA(R1) AAGCTGTCAAACATGAGAACCAAGG
AGAATGTTTTGGTATTCTTGTTCAA
This study
ISAmlaA(F2) GAATTGTTTTAGTACCTAGCCAAGGT
GTGCATTTATATCCATTCTTGCGT
This study
ISAmlaA(R2) AGAATACTCAAGCTTGCATGCCTGCAGG
TCGCCAGTTGTTATTATCATTG
This study
pCJC1mlaA(F) CCCCCATGGTTTTAGGAGTTTT
TGCTGAGAATAAAATTTATATC
This study
pCJC1mlaA(R) CCCGCTAGCTTATTTGCTAAGTTCATTG This study
pRRAmlaA(F) ACACTCTAGATTTAGGAGTTTTTGCTTG This study
pRRAmlaA(R) ACACCAATTGGATTAAAAATATTTT
TTTCATTAA
This study
qRTmlaA(F) GATCCTACTTGGGCAAGTATAGC This study
qRTmlaA(R) ATGCTTACGAGCAAAGACGCAATG This study
qRTmlaC(F) CCACTTCTATGGTAGTAGATGGG This study
qRTmlaC(R) GTAGGGCATCAAAGCCTTGGTT This study
rpoA(F) CGAGCTTGCTTTGATGAGTG Ritz et al., 2009
rpoA(R) AGTTCCCACAGGAAAACCTA Ritz et al., 2009
GS, gene specific; ISA, isothermal assembly; pRRA, C. jejuni complementation vector;
pCJC1, C. jejuni complementation vector; qRT, quantitative reverse transcription PCR.
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(Gundogdu et al., 2011; Jervis et al., 2015). Briefly, the complete
wild-type gene was amplified by PCR to contain the native
ribosome binding site, start codon, and stop codon with primers
pCJC1mlaA(F/R) (Table 1) to introduce a Nco1 site at the 5′ end
and a Nhe1 sit at the 3′ end. The amplified gene was digested with
Nhe1 and Nco1 and ligated into the pCJC1 complementation
vector which was used to insert the wild-type gene copy into
the 488 ortholog of the C. jejuni 11168 pseudogene cj0223.
Putative clones were selected on BA plates supplemented with
chloramphenicol then verified by PCR and sequencing. In the
488 mlaA complement strain, the inserted mlaA gene is under
the control of a constitutive chloramphenicol promoter.
3,3′-dipropylthiadicarbocyanine Iodide
(DiSC3) Permeability Assay
DiSC3 is a potentiometric fluorescent probe which accumulates
on, and translocates into, hyperpolarized lipid bilayers and
is frequently used to measure membrane permeability.
Fluorescence was monitored at Ex/Emwavelength of 622/670 nm
in a Cary Eclipse (Agilent, United States) fluorescence
spectrophotometer. C. jejuni cells were washed in 20mM
sodium phosphate buffer, pH 7.4, containing 10mMKCl, and set
to an optical density at 600 nm of 0.1. DiSC3 was added to 5µM
final concentration and fluorescence emission followed for 2min
to establish the baseline. Polymyxin B was then added (100µM
final concentration) and emission followed for a further 1min,
before the addition of SDS (20mM final concentration) to give
the maximum fluorescence value. Percentage incorporation of
the dye into the membrane was calculated by:
100−
(
emission after Polymyxin B
(
minus baseline
)
maximum emission after SDS
(
minus basline
)
)
× 100
Growth Kinetics and Membrane
Sensitivity Assays
The growth of each C. jejuni wild-type, mutant and complement
strains was characterized by measuring both the OD600 value
and colony forming units (CFUs) of a liquid culture every
2 h for 18 h. Sensitivity to the bile salt sodium taurocholate
at biologically relevant concentrations was analyzed measuring
OD600 and CFU of liquid cultures supplemented with 0.2%
(w/v) ST every 2 h for 18 h. Sensitivity to ST at high
concentrations was analyzed by comparing the OD600 and
CFU of late-log phase broth cultures in the presence or
absence of 2% (w/v) sodium taurocholate. Sensitivity to the
zwitterionic detergent lauryl sulfobetain (LSB) was analyzed by
comparing CFUs of mid-log phase cultures serially diluted and
spotted onto Brucella agar with or without supplementation
of LSB (1.25mM final concentration). Sensitivity to polymyxin
B was analyzed by comparing CFUs of mid-log phase
cultures serially diluted and spotted onto BA plates with
and without supplementation with polymyxin B (2.5µg/ml
final concentration).
Outer Membrane Vesicle Isolation
C. jejuniOMVs were isolated as previously described (Elmi et al.,
2012). Briefly, C. jejuni from a 24 h BA plate were resuspended
in Brucella broth and used to inoculate 50ml of pre-equilibrated
Brucella broth to an OD600 of 0.1. Cultures were grown to
late-log phase, time points determined by growth kinetics for
each strain. OD600 values were normalized to OD600 1.0 and
the sterile supernatants obtained by pelleting cells and filter-
sterilizing supernatants through a 0.22µmmembrane (Millipore,
United Kingdom). The supernatants were then concentrated to
2ml using an Ultra-4 Centrifugal Filter Unit with a nominal
10 kDa cut-off (Millipore). The concentrated filtrate was ultra-
centrifuged at 150,000 × g for 3 h at 4◦C using a TLA 100.4
rotor (Beckman Instruments, United States). The resulting OMV
pellet was washed by resuspending in phosphate buffered saline
(PBS) and pelleting by ultra-centrifugation as described above.
All isolation steps were performed at 4◦C and the resultingOMVs
pellet was resuspended in PBS and stored at−20◦C.
Quantification of Outer Membrane Vesicles
The protein concentration of OMV preparations was quantified
using a commercial bicinchoninic-acid (BCA) assay kit
according to the manufactures protocol (Thermo Fisher
Scientific, United Kingdom), using BSA as the protein standard.
The lipo-oligosaccharide of OMV preparations was quantified
by measuring 2-Keto-3-deoxyoctonate acid (KDO) content
as described previously (Lee and Tsai, 1999). Briefly, 50 µl
samples were hydrolysed with 50 µl sulphuric acid (0.5N)
at 100◦C for 15min, then mixed with 50 µl 0.1M periodate
reagent (H5IO6) and incubated at room temperature for 10min.
200 µl 4% (w/v) sodium arsenite reagent (NaAsO2) then 800
µl 0.6% (w/v) thiobarbituric acid was added and samples
heated again to 100◦C for 15min. Samples were mixed with
1ml dimethyl sulfoxide (DMSO) to stabilize the chromophore
and OD548 measurements taken. 2-Keto-3-deoxyoctonate
ammonium salt (Sigma-Aldrich, United Kingdom) was used as
the KDO standard.
Analysis of Outer Membrane Vesicles by
Nanoparticle Tracking Analysis
Nanoparticle tracking analysis (NTA) was conducted using
a ZetaView PMX 110 instrument (Particle Metrix GmbH,
Germany) following the manufacturer’s instructions. The
instrument was calibrated against a known concentration
of PS100 nanoparticles with 100 nm diameter (Applied
Microspheres B. V., The Netherlands). Nanostandards and OMV
samples were suspended in particle-free PBS (Sigma-Aldrich)
and diluted appropriately before analysis. Each sample was
counted and sized across two cycles of 11 frames per cycle with a
flow cell sensitivity of 80%.
Quantitative Real-Time Polymerase Chain
Reaction (qRT-PCR)
To investigate the expression of mlaA and mlaC, total RNA
from both the C. jejuni 11168 and 488 wild-type strains, grown
in Brucella broth to mid-log phase either in the presence or
absence of 0.2% (w/v) sodium taurocholate was extracted using
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FIGURE 1 | Comparison using the Artemis Comparison Tool (ACT) (Carver et al., 2005) software of the gene clusters containing (A) mlaAC and (B) mlaEDF using the
C. jejuni 11168 original genome sequenced strain from the Sanger public database (ID CJ11168 accession number AL111168) and the new sequences of the 11168
and 488 wild-type strains produced here. Below each ACT window is the conserved organization of the mla gene clusters for the strains used in this study based on
synteny between the annotated AL111168 genome sequence and the newly sequenced strains in this study. The color qualifier for annotated gene sequences was
based on gene function following the scheme adopted by the Wellcome Trust Sanger Institute Pathogen Genomic Department. Functional colors included in this figure
are: yellow (central/intermediary/miscellaneous metabolism); dark green (surface–IM, OM, secreted, surface structures); white (pathogenicity/Adaptation/Chaperones);
red (information transfer–transcription/translation + DNA/RNA modification); orange (conserved hypothetical), and dark gray (energy metabolism).
Invitrogen PureLink RNA kit (Invitrogen, United Kingdom).
DNA contamination was removed using the TURBO DNA-free
kit (Thermo Fisher Scientific). Purified RNA was quantified
using a NanoDrop machine (NanoDrop Technologies,
United Kingdom) and used to synthesize complementary
DNA (cDNA) using the SuperScript III First-Strand Synthesis kit
(Thermo Fisher Scientific). qRT-PCR reactions were performed
in triplicate using SYBR green master mix (Thermo Fisher
Scientific) and an ABI7500 machine (Applied Biosystems).
Relative gene expression comparisons were performed using the
11CT (cycle threshold) method (Schmittgen and Livak, 2008)
and previously published C. jejuni rpoA primers (Ritz et al.,
2009) for internal controls to normalize the mean CT of each
gene to the stably expressed housekeeping gene rpoA.
Statistical Analysis
At least three biological replicates were performed each
in triplicate for each experiment. Statistical analyses were
performed using Prism software (GraphPad Software). Variables
were compared using a student’s t-test or a one sample t-test with
∗ indicating a p < 0.05, ∗∗ indicating a p < 0.01, ∗∗∗ indicating a
p< 0.001, and ∗∗∗∗ indicating a p< 0.0001.
RESULTS
Identification of C. jejuni Orthologs of the
MLA Pathway in E. coli
The genomes of C. jejuni 11168 and 488 contain sets of genes
encoding proteins homologous to components of the MLA
pathway in E. coli and the VacJ and YrbCEFD proteins in H.
influenzae. TheMLA pathway consists ofMlaA (outermembrane
lipoprotein), MlaC (periplasmic chaperone), and MlaEFD (inner
membrane ABC transporter). In C. jejuni these proteins are
encoded in two separate regions of the genome (Figure 1).
Cj1371 and Cj1372 in C. jejuni 11168 are within the same
gene cluster and are homologous to MlaA and MlaC in E. coli
(amino acid sequence similarity of 29.4 and 21.6%, respectively,
to E. coli MG1655 MlaA and MlaC) and VacJ and YrbC in
H. influenzae (amino acid sequence similarity of 25.8 and
22.2%, respectively, to H. influenzae KW20 VacJ and YrbC).
Homologous proteins were also identified in C. jejuni 488 with
97.4 and 96.8% amino acid similarity to Cj1371 and Cj1372,
respectively. Cj1646, Cj1647, and Cj1648 in C. jejuni 11168
are encoded by the same gene cluster and are homologous
to MlaEFD in E. coli (amino acid sequence similarity of 27.6,
31.8, and 18.8%, respectively, to E. coli MG1655 MlaEFD), and
YrbEFD inH. influenzae (amino acid sequence similarity of 27.7,
36.4, and 22.8%, respectively, to H. influenzae KW20 YrbEFD).
Homologous proteins were also identified in C. jejuni 488 with
98.1, 99.2, and 97.6% amino acid similarity to Cj1646, Cj1647,
and Cj1648, respectively. mlaB or yrbB were absent in the C.
jejuni strains used in this study. ε proteobacteria have previously
been reported to lack mlaB homologs (Roier et al., 2016). The
MLA nomenclature will be used for this study. The C. jejuni
11168 published annotated whole genome sequence (Sanger
database: ID CJ11168 accession number AL111168) has assigned
color qualifiers based on predicted functionality. MlaDEFC are
predicted to be functionally linked to cell surfaces (IM, OM,
secreted, surface structures). MlaA is predicted to be functionally
linked to pathogenicity, adaptation, and chaperones (Figure 1).
No Change in Sensitivity of mlaA Mutant to
Detergent Compared to Wild-Type Strains
As the MLA pathway is proposed to play a role in the
maintenance of the bacterial OM (Malinverni and Silhavy, 2009),
the membrane integrity of the mlaAmutants was investigated to
ensure any changes in OMV production were not an artifact of a
fragile OM.Membrane permeability of the C. jejuni 11168 parent
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FIGURE 2 | Membrane permeability of the C. jejuni 11168 wild-type strain,
isogenic mlaA deletion mutant (1mlaA), and complemented (+mlaA) strain.
Permeability of intact cells was measured using the fluorescent probe
3,3’-Dipropylthiadicarbocyanine Iodide (DiSC3) which accumulates on, and
translocates into, hyperpolarized lipid bilayers. Cells were washed prior to the
assay, removing OMVs, to measure parent cell membrane permeability.
Polymyxin B was added to the cells at a final concentration of 100µM and
release of DiSC3 from the membrane was measured. SDS was added at a
final concentration of 20mM to measure maximum fluorescence.
cell membranes in the absence of OMVs was analyzed using the
DiSC3 assay. C. jejuni cells were washed (removing OMVs) then
re-suspended in assay buffer. There was no significant difference
in percentage incorporation of the dye after membrane stress
with 100µMfinal concentration polymyxin B between the 11168
wild-type,mlaAmutant or complement strain (Figure 2).
Growth or survival during culture conditions in the presence
of detergents (LSB and ST) were used to investigate membrane
integrity. No significant difference in growth rates measured by
either OD600 readings or CFUs was observed prior to stationary
phase for either the mlaA mutant or the complemented mutant
when compared to the respective wild-type strain. There was
also no significant difference observed for any strain when
grown in the presence of 0.2% (w/v) ST (biologically relevant
concentration) compared to the same strain cultured in Brucella
broth alone prior to stationary phase. The C. jejuni 11168 strain
was able to grow to higher CFU and OD600 values than the C.
jejuni 488 strain (Figure S1).
Survival of bacteria in the presence of high concentrations
of detergent was investigated either by plating bacteria onto
agar supplemented with 1.25mM LSB or by culturing bacteria
in Brucella broth supplemented with 2% (w/v) ST. Survival of
both the mlaA mutant and complement strains was comparable
to the corresponding wild-type strains for both detergents
(Figures 3A,B). 1.25mM LSB caused around a 4-log reduction in
growth for 11168 strains compared to around a 2-log reduction
for 488 strains. Less than a log reduction in growth was observed
for bacteria cultured in 2% (w/v) ST (Figure 3B).
mlaA Mutants Exhibit Increased
Resistance to Polymyxin B
Polymyxin B targets cells through binding to LOS or
lipopolysaccharide (LPS), meaning OMVs are capable of binding
polymyxin B in the extracellular environment (Manning and
Kuehn, 2011). Resistance to a low concentration of polymyxin
B (2.5µg/ml) was used as an initial screen for increased OMV
production in themlaAmutants compared to the respective wild-
type strains. The C. jejuni 11168 and 488 mlaA mutants were
significantly more resistant to polymyxin B compared to their
wild-type strains under culture conditions. Complementation of
the 11168 mlaA mutant with the mlaA gene under the control
of the native promotor almost completely restored wild-type
polymyxin B sensitivity, however, complementation of the
488 mlaA mutant with the mlaA gene under the control of a
constitutive chloramphenicol promotor did not. It would appear
that the expression of the inserted mlaA gene in the 488 mlaA
complement is not sufficient to restore the wild-type phenotype
under these stress conditions (Figure 3C).
mlaA Mutation Results in Increased OMV
Production
Total protein and KDO concentration were used to quantify
OMV preparations. KDO is a component of LOS and can
be used to indicate the amount of OM present. As protein
and KDO concentrations are unable to determine if OMV
preparations contain more OMVs or larger OMVs, NTA was
used to verify any changes in production. OMV preparations
were from bacterial cultures of equivalent volume and OD600
readings. OMV preparations isolated from the C. jejuni 11168
mlaA mutant had significantly higher concentrations of both
protein and KDO compared to the wild-type and complement
strains (Figure 4). The OMV preparations of the mlaA mutant
strains were also confirmed to contain more OMVs by NTA
particle counts (Figure S2).
Co-culture With Sodium Taurocholate
Increases Lipid and Protein Concentration
of C. jejuni OMVs
To investigate the link between ST and OMV production
proposed by Elmi et al. (2018), OMVswere isolated fromC. jejuni
11168 wild-type, mlaA mutant, and complement strains co-
cultured with 0.2% (w/v) ST. OMV preparations isolated from ST
supplemented cultures had significantly higher concentrations of
KDO for the wild-type and complement strains (Figure 5). ST
did not increase the KDO concentration of the mlaA mutant
OMV preparations. Protein concentrations were significantly
higher for the wild-type strain in the presence of ST and higher,
but not significantly so for the mlaA complement strain. The
protein concentration did not increase in the presence of ST for
the mlaA mutant (Figure 5). The increase in OMVs based on
KDO and protein concentrations in the presence of ST for the
wild-type and complement strain also correlated to an increase
in particle number for NTA (Figure S2).
Changes in Lipid and Protein
Concentration of OMVs Are Inversely
Proportional to OMV Size
In addition to quantifying OMV production levels, the size
of the OMVs produced were also investigated by NTA. OMV
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FIGURE 3 | Survival of C. jejuni strains exposed to detergent stress or detergent-like stress. (A) Mid-log phase cultures spotted onto Brucella agar in the presence or
absence of 1.25mM lauryl sulfobetaine. (B) Late-log phase cultures grown in Brucella broth in the presence or absence of 2% (w/v) sodium taurocholate. (C) Mid-log
phase cultures spotted onto blood agar in the presence or absence of 2.5µg/ml polymyxin B. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
preparations from all strains and all conditions contained one
main size cluster which contained 92–99% of the population.
An increase in protein, KDO and particle number either
in the presence of ST or in the absence of a complete
MLA pathway correlated to a reduction in OMV size. OMVs
isolated from the C. jejuni 11168 wild-type, mlaA mutant,
and mlaA complement strain had a mode diameter of 177,
140, and 184 nm, respectively, when isolated from cultures
grown in Brucella broth. When co-cultured with 0.2% (w/v)
ST, ST-OMV mode diameters were 137, 133, and 159 for the
11168 wild-type, mlaA mutant, and mlaA complement strains,
respectively (Figure 6). A similar inverse correlation between
OMV quantity and size was also observed for mean OMV
diameters (Figure S2).
Co-culture of C. jejuni With Sodium
Taurocholate Results in Reduced Gene
Expression of mlaA and mlaC
As the C. jejuni 11168 mlaA mutant was not observed to
increase OMV production in the presence of 0.2% (w/v) ST
in contrast to the wild-type strain, the effect of 0.2% (w/v)
ST on the relative expression of genes encoding components
of the MLA pathway was investigated. mlaA and mlaC were
selected for investigation. RNA was isolated from mid-log phase
cultures of the C. jejuni 11168 and 488 wild-type strains. A
statistically significant approximate 2-fold down-regulation of
gene expression of bothmlaA andmlaC in both wild-type strains
(11168 and 488) in the presence of ST compared to the absence of
ST, was observed relative to the rpoA internal control (Figure 7).
DISCUSSION
Previous characterizations of the cargo of C. jejuni OMVs
have identified biologically active compounds that contribute
to immunogenicity, cytotoxicity, and the breakdown of the gut
barrier mediated by bacterial proteases (Jang et al., 2014; Elmi
et al., 2016, 2018). The mechanisms regulating OMV production
in C. jejuni however, are still poorly understood. In this study,
we have characterized both the role of the MLA pathway in C.
jejuniOMV production, as well as the role of ST in regulating the
MLA pathway. OMV production in C. jejuniwas increased either
in the presence of a biologically relevant concentration of ST or
in the absence of a complete MLA pathway, linking the model
proposed by Roier et al. (2016) with the ST phenotype observed
by Elmi et al. (2018).
Despite the bacteriostatic effect of bile salts (Begley et al.,
2005), in this study C. jejuni was shown to be highly tolerant to
ST stress, showing less than a log-reduction in growth at 2% (w/v)
ST, a concentration higher than is considered to be biologically
relevant (Elmi et al., 2018). This then suggests that much lower
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 May 2019 | Volume 9 | Article 177
Davies et al. Sodium Taurocholate Stimulates C. jejuni OMVs
FIGURE 4 | Mutation of mlaA increases OMV production. OMVs were isolated from late-log phase C. jejuni 11168 cultures grown in Brucella broth. OMV preparations
from cultures of C. jejuni 11168 wild-type, mlaA mutant, and complement strains of equivalent OD600 values were quantified by analyzing (A) total KDO as a
measurement of LOS and (B) total protein. **p < 0.01; ***p < 0.001; ****p < 0.0001.
FIGURE 5 | The presence of a biologically relevant concentration of ST increases OMV production in C. jejuni wild-type strain but not in the mlaA mutant. OMVs were
isolated from late-log phase C. jejuni cultures grown in Brucella broth either in the presence or absence of 0.2% (w/v) ST. OMV and ST-OMV preparations from
cultures of C. jejuni wild-type, mlaA mutant and complement strains of equivalent OD600 values were quantified by analyzing (A) total KDO as a measurement of LOS
and (B) total protein **p < 0.01.
FIGURE 6 | Mutation of mlaA or ST exposure increase OMV particle numbers not OMV size. OMVs were isolated from late-log phase C. jejuni cultures grown in
Brucella broth either in the presence or absence of 0.2% (w/v) ST. OMV preparations from cultures of C. jejuni wild-type, mlaA mutant, and complement strains of
equivalent OD600 values were sized by nanoparticle tracking analysis using a PMX 110 ZetaView instrument. (A) OMV mode diameter, (B) OMV compared to ST-OMV
mode diameter. *p < 0.05; **p < 0.01; ****p < 0.0001.
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FIGURE 7 | qRT-PCR analysis of mlaA and mlaC transcription in C. jejuni
11168 and 488 wild-type strains co-incubated with 0.2% (w/v) sodium
taurocholate. Analysis was performed using mlaA, mlaC, and rpoA gene
specific primers. rpoA was used as an internal control. 2∧(−ddCT ) = fold
change in gene expression compared to C. jejuni grown in the absence of ST.
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
and biologically relevant concentrations of ST could act as stimuli
without compromising bacterial growth or membrane integrity.
This is in agreement with a previous study (Elmi et al., 2018),
which did not observe any defect in growth of C. jejuni associated
with a biologically relevant concentration of ST (0.2% w/v). The
effect of a combination of bile salts similar to that expected to
be found in the human gut was not investigated in this study,
however, the resistance to ST demonstrated here highlights the
exquisite adaptation of C. jejuni to the gut environment where
localized signals co-ordinate bacterial behavior.
There is conflicting evidence in the literature regarding the
impact of mla mutations on membrane integrity. Malinverni
and Silhavy (2009) observed increased sensitivity of E. coli mla
mutants to SDS in combination with EDTA, but not to SDS alone.
EDTA is a chelating compound that is thought to destabilize
LPS to increase membrane permeability (Finnegan and Percival,
2015). The metabolic cost, rather than the membrane integrity
of the E. coli mla mutants unable to down-regulate OMV
production as well as patching areas effected by EDTA, could
be the more likely cause of the increased mutant sensitivity.
Abellon-Ruiz et al. (2017) observed growth defects in an E. coli
mlaA mutant compared to the wild-type strain in the presence
of both doxycycline and chlorpromazine. This suggested that
the PL accumulation at the OM created transient patches of
PL bilayer creating windows of opportunity for small molecules
that are readily able to diffuse through PL bilayers to enter
the cell. However, as an mla mutant is unable to down-
regulate the creation of these PL bilayer patches, this membrane
defect phenotype would be less applicable to a wild-type strain
which would be able to up-regulate OMV production without
compromising integrity in favorable conditions and down-
regulate production reducing the creation of these patches in
unfavorable conditions. Roier et al. (2016) also did not observe
any obvious membrane defects for the mla mutants in response
to detergent stress, supporting the model that increased OMV
production is due to a regulated process and is not an artifact of
an unstable membrane.
As the membrane of an OMV contains either LOS or LPS,
it has been suggested OMVs can confer protection against
compounds that target or bind to this component of the bacterial
membrane, such as bacteriophage or polymyxin B. This was
demonstrated by a study that examined the ability of OMVs to
protect against low concentrations of polymyxin B (Manning
and Kuehn, 2011). Resistance to this antibiotic is normally
achieved through modifications of LOS or LPS preventing the
antibiotic binding to the bacterial OM. Manning and Kuehn
(2011) observed that only OMVs from polymyxin B sensitive
strains conferred protection against polymyxin B when added
to a culture of a polymyxin B sensitive bacteria, as polymyxin
B was unable to bind to OMVs produced by a polymyxin
B resistant strain. Here we demonstrated that there was no
significant difference in resistance to polymyxin B between
the 11168 wild-type strain and the mlaA mutant when cells
were washed and supernatant discarded to remove OMVs. The
fluorescent probe DiSC3 accumulates on, and translocates into,
hyperpolarized lipid bilayers, so the DiSC3 assay was used to
investigate changes in bacterial membrane permeability. After
the addition of polymyxin B, there was no difference in the
change in bacterial membrane permeability of the mlaA mutant
compared to the 11168 wild-type strain. Based on these results,
resistance to a low concentration of polymyxin B (2.5µg/ml)
under culture conditions was investigated as an initial screen
for increased OMV production by mlaA mutants. A positive
correlation between increased OMV production and polymyxin
B resistance was observed. As OMV isolation is laborious,
this could provide a quick and easy initial screen for OMV
production levels.
Both in this study and in a previous study (Elmi et al.,
2018), a biologically relevant concentration of ST was shown
to stimulate OMV production. 0.2% (w/v) ST was observed to
almost double OMV production by the C. jejuni 11168 wild-type
strain.Mutation ofmlaA increased OMVproduction by the same
magnitude in the absence of ST, whilst ST did not significantly
further stimulate OMV production by the mlaA mutant. This
increase was also shown by NTA to be due to the presence
of increased numbers of OMVs rather than larger OMVs. The
increase in OMV production was also associated with a small
reduction in OMV size. It is possible that this is due to an
increase in PLs in the membrane of the OMVs, based on the
model proposed by Roier et al. (2016), altering the membrane
curvature during the formation of the OMV. The reduced size
of wild-type ST-OMVs was also similar to that of the mlaA
mutant OMVs. Both the mlaA mutant OMVs and wild-type ST-
OMVs had comparable diameters. This is in contrast to data
from a recent study (Taheri et al., 2018) which did not observe
increased OMV production in response to ox bile. Ox bile was
used to represent a mixture of bile salts, similar to what would
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be found in the gut, whereas ST alone was used in this study, a
single component of human bile. Bile composition not only varies
between species but also between individuals of the same species,
as well as depending on the location in the gut (Sjövall, 1959;
Falany et al., 1994; Nagana Gowda et al., 2009; Chiang, 2017).
For example, in humans the proportion of taurine to glycine
conjugated bile salts is diet determined. Humans with a taurine
rich diet (animal-based products) will have a higher proportion
of taurine conjugated bile salts compared to low taurine diet
(Sjövall, 1959; Wojcik et al., 2010; Ridlon et al., 2016). As oxes
are herbivores, the bile pool composition maybe low in taurine
conjugated bile salts, such as sodium taurocholate. Previous work
by Elmi et al. (2018) found the effect of sodium taurocholate
on OMV production to be dose-dependent. The low dose of
ox bile used in this other study, along with the potentially low
proportion of taurine conjugates within the ox bile, could explain
the different results observed between these studies.
Roier et al. proposed that iron limitation regulates the MLA
pathway in H. influenzae, V. cholera, and E. coli in a Fur
dependent manner. However, a RNA sequencing study did not
highlight a link between Fur and the MLA pathway in C. jejuni
(Butcher et al., 2015). As ST has previously been linked to
C. jejuni virulence and OMV production, ST was investigated
as a potential regulator of the C. jejuni MLA pathway. The
differential effect ST had on OMV production in the C. jejuni
11168 wild-type strain compared to the mlaA mutant suggests
a direct interaction between ST and the MLA pathway in C.
jejuni. These are the first data suggesting a role for bile salts in
regulating the MLA pathway. The qRT-PCR results in this study
showed around a 2-fold down-regulation of mlaA and mlaC in
response to ST exposure, further strengthening the hypothesized
interaction between ST and the MLA pathway in C. jejuni.
As previous studies have suggested removing one component
of the MLA pathway prevents functionality (Malinverni and
Silhavy, 2009; Roier et al., 2016), this could explain why ST
appeared to have no effect on OMV production in a single
mlamutant.
In summary, the data in this study suggests C. jejuni can
regulate OMV production in response to host gut signals
through changes in expression of the MLA pathway. Increased
OMV production without compromising membrane stability
was observed in a mlaA mutant and a potential mechanism
for the ST-OMV phenotype was identified. In the presence
of ST, OMV production was shown to increase in the wild-
type strain, but not in a mlaA mutant. Growth of C. jejuni
in the presence of ST also resulted in reduced expression of
both mlaA and mlaC. Our data supports the MLA model
of OMV production and the link between bile salts and
potential virulence regulation in C. jejuni. As the gut bile
composition is dependent on both diet and the microbiota, this
study highlights the potential importance of diet and lifestyle
factors on the varying disease presentations associated with gut
pathogen infection.
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Figure S1 | Growth curves of C. jejuni 11168 wild-type strain compared to the
488 wild-type strain. Strains were grown in Brucella broth under microaerobic
conditions at 37◦C. Growth was characterized by measuring (A) OD600 values
and (B) colony forming units (CFUs) every 2 h for 18 h.
Figure S2 | Mutation of mlaA or ST exposure increase OMV particle numbers not
OMV size. OMVs were isolated from late-log phase C. jejuni cultures grown in
Brucella broth either in the presence or absence of 0.2% (w/v) ST. OMV
preparations from cultures of C. jejuni wild-type, mlaA mutant, and complement
strains of equivalent OD600 values were sized by nanoparticle tracking analysis
using a PMX 110 ZetaView instrument. (A) Particle counts per ml and (B) OMV
mode diameter, mean and median diameters (nm).
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